Parallax Volatility Advisers, L.P. Catalent, Inc. Transaction History

Parallax Volatility Advisers, L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$42.56 - $59.82 $595,456 - $836,941	13,991 New	13,991 $789,000
Q1 2023 May 15, 2023	BUY	$45.44 - $74.26 $94,424 - $154,312	2,078 New	2,078 $136,000
Q2 2020 Aug 14, 2020	SELL	$48.02 - $79.04 $514,246 - $846,439	-10,709 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$36.95 - $62.95 $31,111 - $53,003	842 Added 8.53%	10,709 $556,000
Q2 2019 Aug 14, 2019	SELL	$39.26 - $54.21 $202,856 - $280,103	-5,167 Reduced 34.37%	9,867 $535,000
Q1 2019 May 15, 2019	BUY	$29.84 - $43.92 $448,614 - $660,293	15,034 New	15,034 $610,000
Q1 2018 May 15, 2018	SELL	$39.4 - $47.39 $802,578 - $965,334	-20,370 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$37.27 - $43.02 $759,189 - $876,317	20,370	20,370 $837,000

422

147M

571K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.